Adrenal
|
September 2, 2024

Diagnosing Cushing's Syndrome: What to Expect

Medically Reviewed by
Updated On
November 8, 2024

Cushing's syndrome is a complex endocrine disorder characterized by excessive cortisol production resulting from prolonged corticosteroid use (exogenous) or the body's overproduction of cortisol (endogenous). 

This excess cortisol disrupts many bodily functions, leading to symptoms such as muscle weakness, weight gain, and increased risk of cardiovascular disease. This can leave patients feeling overwhelmed and possibly challenged when describing their experience to their doctor.

In this article, we’ll dive into the symptoms that can indicate whether additional assessment for Cushing’s syndrome is appropriate, helping patients and practitioners close the gap between symptom onset and diagnosis.

[signup]

What is Cushing's Syndrome?

Cushing's syndrome is characterized by excess cortisol, often resulting from prolonged corticosteroid use (exogenous) or, less commonly, from the body's overproduction of cortisol (endogenous). 

Cushing's disease, a subtype of endogenous Cushing's syndrome, is specifically caused by a benign pituitary tumor that overproduces adrenocorticotropic hormone (ACTH), leading to excessive cortisol production by the adrenal cortex

It highlights the role of the adrenal gland, kidney, and the excessive release of adrenaline from the adrenal gland associated with Cushing's Syndrome.

While Cushing's disease accounts for 80% of endogenous cases, exogenous Cushing's syndrome, primarily caused by prolonged corticosteroid use, is now more common due to widespread glucocorticoid treatments.

Cortisol is a glucocorticoid hormone that regulates metabolism, modulates the immune response, directs the stress response, and is necessary for healthy fetal development

However, excessive cortisol, as seen in Cushing's syndrome, disrupts these functions, leading to muscle weakness, osteoporosis, hyperglycemia, weight gain, hypertension, and increased risk of cardiovascular disease. 

Prolonged high cortisol levels also contribute to neuropsychiatric issues, including emotional instability, depression, anxiety, and cognitive deficits.

Common Symptoms of Cushing's Syndrome

Cushing’s syndrome and Cushing’s disease cannot be differentiated by symptoms alone. Identifying patients with symptoms of excess cortisol requires additional diagnostic procedures to determine the root cause of high cortisol.

Common symptoms of Cushing’s syndrome include: 

  • Skin Changes: thinning skin, slow wound healing, and purple stretch marks (striae) on the abdomen and thighs are all due to disrupted collagen production.
  • Muscle Weakness: muscle wasting, especially in the limbs, causes a contrast between a large belly and thin arms and legs.
  • Metabolic Issues: glucose and lipid metabolism abnormalities are common, with insulin resistance, hyperglycemia, and hyperlipidemia being associated with high cortisol levels. 
  • Other Symptoms: Increased thirst, urination, headaches, visual disturbances, and decreased immunity, which may be mistaken for other conditions like diabetes or cardiovascular disease.

Initial Consultation: Recognizing Symptoms and Taking a Medical History

Cushing’s syndrome is rare outside of excessive or chronic glucocorticoid use. However, symptom recognition and the diagnostic process can take years, so discussing concerns with your primary care provider is essential. 

This timeline is often due to the variability and subtlety of symptoms, making diagnosis challenging.

Most often, patients will first discuss their health concerns with their primary care provider, who will ask additional questions about the individual’s current symptoms and medical history. A medical examination is also often performed. 

Identifying Symptoms

Key symptoms that may indicate Cushing’s syndrome often include the characteristic central weight gain pattern, loss of muscle mass in limbs, muscle weakness, skin changes, loss of bone density, increased infections, hyperglycemia and hyperlipidemia, and hypertension

Providers should also question patients about changes in their mood or cognitive abilities. 

The symptom picture for Cushing’s syndrome often mimics cardiometabolic conditions like  diabetes or heart disease, so clinicians should keep Cushing’s syndrome in mind when any concern for this condition arises, especially in patients whose symptoms are progressive and/or are unusual for their age. 

Detailed Medical History

A comprehensive medical evaluation will include the patient’s medication use. Clinicians concerned about Cushing’s syndrome should be on the lookout for chronic glucocorticoid use as well as other medications that can cause Cushing’s syndrome. 

For example, megestrol acetate, a synthetic progesterone with glucocorticoid activity, has been associated with Cushing’s syndrome.

Clinicians should also ask about using specific herbs, including licorice, an 11β-HSD2 inhibitor, anti-inflammatory joint injections, and topical products that might contain glucocorticoids. 

Additionally, the patient's medical and family history should be reviewed, particularly regarding previous endocrine issues. 

Physical Examination

A physical exam will be performed to look for symptoms consistent with Cushing’s syndrome.

Doctors look for highly discriminatory signs of Cushing's syndrome, including easy bruising, facial redness, muscle weakness, and striae, mainly when they are reddish purple and greater than 1 cm wide. 

In children, a notable sign is weight gain accompanied by a concurrent decrease in growth velocity. 

Additionally, more common but less specific signs of the syndrome include the presence of a dorsocervical fat pad (also known as a "buffalo hump"), facial fullness (“moon facies”), obesity, supraclavicular fullness, thin skin, peripheral edema, acne, hirsutism or female-pattern balding, and poor skin healing.

Blood pressure should be measured, as Cushing's syndrome is often associated with hypertension, especially when it occurs at a younger-than-expected age.

Recent laboratory studies may also demonstrate hypokalemia (low potassium), impaired glucose tolerance or diabetes, and/or dyslipidemia (elevated cholesterol and triglycerides). 

Laboratory Tests for Diagnosing Cushing's Syndrome

A doctor will begin by ordering initial screening tests and may order additional follow-up testing and imaging studies [29., 30., 32.].

Initial Screening Tests

  • 24-Hour Urinary Free Cortisol Test
    • This test measures cortisol levels in the urine over a 24-hour period to provide an integrated assessment of cortisol secretion uninfluenced by cortisol-binding globulin (CBG) levels. 
  • Elevated cortisol levels on this test indicate excessive cortisol with high sensitivity, especially when at least two collections are made to confirm the results.
  • Late-Night Salivary Cortisol Test
    • This test measures cortisol levels in saliva late at night, typically between 11:00 PM and midnight, when cortisol levels are generally at their lowest.
  • It demonstrates the loss of the normal circadian rhythm of cortisol secretion, which is characteristic of Cushing's syndrome.
  • Dexamethasone Suppression Test: this test can be done overnight or for up to 48 hours to determine the body’s response to dexamethasone, which will slow cortisol production in healthy people.
  • Overnight Dexamethasone Suppression Test
    • Involves administering 1 mg of dexamethasone orally at night and measuring serum cortisol the next morning. Inadequate suppression of cortisol suggests Cushing's syndrome.
  • Cortisol levels less than 1.8 μg/dl are suppressed, indicating a normal response.
  • 48-Hour Low-Dose Dexamethasone Suppression Test (2 mg/day)
    • Administers 0.5 mg of dexamethasone every six hours for 48 hours, with serum cortisol measured six hours after the last dose.
  • This test is considered more specific in excluding pseudo-Cushing's syndrome (PCS) and helps confirm Cushing's syndrome.
  • Sensitivity is reported as 100%, and specificity as 88%.

Confirmatory Tests

  • Midnight Serum Cortisol Test (Sleeping and Awake)
    • Measures serum cortisol at midnight, either during sleep or while awake, to detect the absence of the normal midnight cortisol drop, a key sign of Cushing's syndrome.
  • Blood draw requires specific procedures depending on whether the patient is asleep or awake.
  • The loss of the normal cortisol drop at night confirms Cushing's syndrome, especially in cases with mild or cyclical disease.
  • Plasma ACTH Levels
    • Plasma ACTH levels differentiate between ACTH-dependent and ACTH-independent forms of Cushing's syndrome.
  • Elevated ACTH levels (>4.4 pmol/L) typically indicate an ACTH-dependent source such as Cushing's disease (CD) caused by a pituitary adenoma or ectopic ACTH production from non-pituitary tumors.
  • Suppressed ACTH levels (<2.2 pmol/L) suggest an ACTH-independent form of Cushing's syndrome, such as an adrenal adenoma or carcinoma, which autonomously produces cortisol and suppresses ACTH secretion.
  • Low-Dose Dexamethasone Suppression Test (LDDST) with CRH Stimulation
    • Combines dexamethasone suppression with CRH stimulation to assess cortisol and ACTH response.
  • This test differentiates between Cushing’s disease and other causes of Cushing's syndrome by assessing the response to CRH after dexamethasone suppression. It’s particularly useful in patients with equivocal results from other tests.
  • CRH is administered after completing a 48-hour dexamethasone suppression test, and cortisol and ACTH levels are measured 15 minutes later.
  • Desmopressin (dDAVP) Test
    • Involves administering desmopressin intravenously and measuring the subsequent rise in ACTH and cortisol levels to differentiate between Cushing's disease (CD) and pseudo-Cushing's syndrome (PCS).

Imaging Studies to Identify the Source of Excess Cortisol

Guidelines for diagnosis of Cushing's syndrome emphasize that imaging, such as pituitary or adrenal imaging, is not recommended for initial testing to diagnose Cushing's syndrome. Instead, the diagnosis should start with biochemical tests to assess cortisol levels.

Imaging tests are typically reserved for later stages in the diagnostic process, specifically after biochemical confirmation of hypercortisolism.

The following imaging studies are used to identify the source of excess cortisol production: 

MRI (Magnetic Resonance Imaging)

Pituitary MRI is recommended for detecting microadenomas (often <10 mm) in suspected Cushing's disease (ACTH-dependent). MRI is highly sensitive to small tumors. Further tests may be needed to confirm the diagnosis if no tumor is found.

CT Scans (Computed Tomography)

Adrenal CT scans are suggested for ACTH-independent Cushing's to detect adrenal adenomas, carcinomas, or hyperplasia. CT can also help locate small ectopic ACTH-producing tumors in the chest, abdomen, or pelvis.

PET Scans (Positron Emission Tomography)

PET scans are used when ectopic ACTH production is suspected but not detected by CT or MRI. 

PET effectively identifies small neuroendocrine tumors with specific tracers, especially when biochemical tests indicate ectopic ACTH production, but conventional imaging (CT or MRI) fails to find a source.

Bilateral Inferior Petrosal Sinus Sampling (BIPSS)

BIPSS differentiates between pituitary and ectopic ACTH sources when imaging is inconclusive. 

It measures ACTH levels from the petrosal sinuses and peripheral blood, with a higher gradient indicating a pituitary source (Cushing's disease). This test is highly sensitive and specific, especially when MRI does not clearly show a tumor.

Differential Diagnosis: Ruling Out Other Conditions

Ruling out conditions with a similar symptom picture is important to arrive at the correct diagnosis.

Conditions with Similar Symptoms

Cushing’s Syndrome from Excessive Corticosteroid or Medication Use

Before running laboratory assessments, a thorough medication and health history assessment should be done to rule this out.

Pseudo-Cushing's Syndrome (PCS) and Subclinical Cushing's Syndrome (SCS)

Pseudo-Cushing’s Syndrome mimics Cushing’s Syndrome but is caused by chronic stress conditions like alcoholism or severe obesity.  Differentiating from true Cushing’s requires tests like the desmopressin test or midnight serum cortisol.

Subclinical Cushing’s Syndrome involves excess cortisol without obvious clinical signs. It is often associated with adrenal incidentalomas and is difficult to diagnose.

Cyclical Cushing's Syndrome

Characterized by fluctuating cortisol levels and intermittent symptoms, cyclical Cushing’s syndrome can be difficult to diagnose. Prolonged testing over a 28-day period or more is often necessary.

Cyclical Cushing's syndrome can be ACTH-dependent or independent, with varying symptom presentations depending on cycle duration and timing. Diagnosis requires at least three hypercortisolism episodes alternating with two normal cortisol periods.

Differentiating Between Cushing's Syndrome and Cushing's Disease

Cushing's syndrome is caused by prolonged high cortisol levels from either endogenous sources (like an adrenal tumor or ACTH-secreting pituitary adenoma) or exogenous sources (such as prolonged corticosteroid use).

Cushing's disease is a specific form of Cushing's syndrome caused by an ACTH-secreting pituitary adenoma. This pituitary adenoma is typically discovered on MRI.

Importance of Accurate Diagnosis

Correct identification of the cause of Cushing's syndrome is necessary because treatment varies based on the source of excess cortisol. 

  • If the syndrome is due to an ACTH-secreting pituitary adenoma (Cushing's disease), the primary treatment is usually surgical removal of the adenoma. For adrenal tumors, adrenalectomy is often required. 
  • If the cause is ectopic ACTH secretion from non-pituitary tumors, treatment focuses on locating and medically managing the tumor. 

Misidentification of the cause could lead to ineffective or harmful treatments, so accurate diagnosis is essential for effective management and improved patient outcomes.

Next Steps After Diagnosis

After diagnosis, treatment and monitoring come next:

Treatment Options

Treatment for endogenous Cushing's syndrome typically involves surgical removal of the cause: transsphenoidal adenomectomy for pituitary tumors, adrenalectomy for adrenal lesions, and tumor resection for ectopic ACTH-secretion. 

Bilateral adrenalectomy is reserved for severe cases or treatment failures. 

Radiation therapy is considered for patients unresponsive to surgery or with recurrent disease.

Medical options include steroidogenesis inhibitors (ketoconazole, metyrapone, mitotane) for those who can't undergo surgery or while awaiting radiation. Pituitary-directed drugs (cabergoline, pasireotide) and glucocorticoid antagonists (mifepristone) are alternatives for persistent disease. Combination therapy may be needed in severe cases.

For exogenous Cushing's syndrome, gradually reducing corticosteroids, especially after prolonged use. Alternate-day dosing and hydrocortisone replacement may also be considered.

Glucocorticoids should only be discontinued when the underlying disease is in long-term remission; otherwise, alternative treatments are necessary. 

Monitoring and Follow-Up

Even after hypercortisolism is controlled, ongoing monitoring is crucial for persistent issues like hypertension, diabetes, and cardiovascular problems. 

Long-term care and regular follow-ups are needed to ensure cortisol levels normalize and to manage Cushing-associated comorbidities, including cardiovascular problems, osteoporosis, and psychiatric symptoms. 

Lifelong monitoring for disease recurrence is recommended to ensure early detection and intervention.

Preparing for Treatment

Preparation and recovery from Cushing's treatment require careful planning and ongoing management. 

Unfortunately, patients can feel unprepared for the lengthy recovery, often citing inadequate information and support from healthcare providers. 

Effective recovery involves not only stopping cortisol replacement medication (CRM) when adrenal function normalizes but also managing persistent symptoms like pain, fatigue, and neuropsychiatric issues. 

Support systems, including family, friends, and support groups, are essential, and patients are encouraged to prioritize rest over physically demanding activities. 

Organizations like the Cushing’s Support and Research Foundation can aid your journey.

[signup]

Key Takeaways

  • Diagnosing Cushing's syndrome requires a thorough evaluation, including medical history, physical exams, specific biochemical tests, and imaging studies to identify the source of excess cortisol.
  • Early detection of Cushing's syndrome can be life-changing; if you notice symptoms like central weight gain, skin changes, or mood disturbances, consult your healthcare provider promptly, especially if you have a history of prolonged corticosteroid use. Timely intervention can prevent complications and improve health outcomes.
  • Effective treatments for Cushing’s Syndrome, including surgery, medical therapy, and radiation, can lead to remission and significant improvement in quality of life; with proper care and support, many patients successfully recover and regain their health.

Cushing's syndrome is a complex endocrine disorder characterized by excessive cortisol production resulting from prolonged corticosteroid use (exogenous) or the body's overproduction of cortisol (endogenous). 

This excess cortisol can disrupt many bodily functions, leading to symptoms such as muscle weakness, weight gain, and increased risk of cardiovascular issues. This can leave patients feeling overwhelmed and possibly challenged when describing their experience to their doctor.

In this article, we’ll explore the symptoms that may suggest whether additional assessment for Cushing’s syndrome is appropriate, helping patients and practitioners close the gap between symptom onset and diagnosis.

[signup]

What is Cushing's Syndrome?

Cushing's syndrome is characterized by excess cortisol, often resulting from prolonged corticosteroid use (exogenous) or, less commonly, from the body's overproduction of cortisol (endogenous). 

Cushing's disease, a subtype of endogenous Cushing's syndrome, is specifically caused by a benign pituitary tumor that overproduces adrenocorticotropic hormone (ACTH), leading to excessive cortisol production by the adrenal cortex

While Cushing's disease accounts for 80% of endogenous cases, exogenous Cushing's syndrome, primarily caused by prolonged corticosteroid use, is now more common due to widespread glucocorticoid treatments.

Cortisol is a glucocorticoid hormone that helps regulate metabolism, modulate the immune response, direct the stress response, and is necessary for healthy fetal development

However, excessive cortisol, as seen in Cushing's syndrome, can disrupt these functions, potentially leading to muscle weakness, osteoporosis, hyperglycemia, weight gain, hypertension, and increased risk of cardiovascular issues. 

Prolonged high cortisol levels may also contribute to neuropsychiatric issues, including emotional instability, depression, anxiety, and cognitive deficits.

Common Symptoms of Cushing's Syndrome

Cushing’s syndrome and Cushing’s disease cannot be differentiated by symptoms alone. Identifying patients with symptoms of excess cortisol requires additional diagnostic procedures to determine the root cause of high cortisol.

Common symptoms of Cushing’s syndrome include: 

  • Skin Changes: thinning skin, slow wound healing, and purple stretch marks (striae) on the abdomen and thighs may occur due to disrupted collagen production.
  • Muscle Weakness: muscle wasting, especially in the limbs, causes a contrast between a large belly and thin arms and legs.
  • Metabolic Issues: glucose and lipid metabolism abnormalities are common, with insulin resistance, hyperglycemia, and hyperlipidemia being associated with high cortisol levels. 
  • Other Symptoms: Increased thirst, urination, headaches, visual disturbances, and decreased immunity, which may be mistaken for other conditions like diabetes or cardiovascular issues.

Initial Consultation: Recognizing Symptoms and Taking a Medical History

Cushing’s syndrome is rare outside of excessive or chronic glucocorticoid use. However, symptom recognition and the diagnostic process can take years, so discussing concerns with your primary care provider is essential. 

This timeline is often due to the variability and subtlety of symptoms, making diagnosis challenging.

Most often, patients will first discuss their health concerns with their primary care provider, who will ask additional questions about the individual’s current symptoms and medical history. A medical examination is also often performed. 

Identifying Symptoms

Key symptoms that may indicate Cushing’s syndrome often include the characteristic central weight gain pattern, loss of muscle mass in limbs, muscle weakness, skin changes, loss of bone density, increased infections, hyperglycemia and hyperlipidemia, and hypertension

Providers should also question patients about changes in their mood or cognitive abilities. 

The symptom picture for Cushing’s syndrome often mimics cardiometabolic conditions like  diabetes or heart disease, so clinicians should keep Cushing’s syndrome in mind when any concern for this condition arises, especially in patients whose symptoms are progressive and/or are unusual for their age. 

Detailed Medical History

A comprehensive medical evaluation will include the patient’s medication use. Clinicians concerned about Cushing’s syndrome should be on the lookout for chronic glucocorticoid use as well as other medications that can cause Cushing’s syndrome. 

For example, megestrol acetate, a synthetic progesterone with glucocorticoid activity, has been associated with Cushing’s syndrome.

Clinicians should also ask about using specific herbs, including licorice, an 11β-HSD2 inhibitor, anti-inflammatory joint injections, and topical products that might contain glucocorticoids. 

Additionally, the patient's medical and family history should be reviewed, particularly regarding previous endocrine issues. 

Physical Examination

A physical exam will be performed to look for symptoms consistent with Cushing’s syndrome.

Doctors look for highly discriminatory signs of Cushing's syndrome, including easy bruising, facial redness, muscle weakness, and striae, mainly when they are reddish purple and greater than 1 cm wide. 

In children, a notable sign is weight gain accompanied by a concurrent decrease in growth velocity. 

Additionally, more common but less specific signs of the syndrome include the presence of a dorsocervical fat pad (also known as a "buffalo hump"), facial fullness (“moon facies”), obesity, supraclavicular fullness, thin skin, peripheral edema, acne, hirsutism or female-pattern balding, and poor skin healing.

Blood pressure should be measured, as Cushing's syndrome is often associated with hypertension, especially when it occurs at a younger-than-expected age.

Recent laboratory studies may also demonstrate hypokalemia (low potassium), impaired glucose tolerance or diabetes, and/or dyslipidemia (elevated cholesterol and triglycerides). 

Laboratory Tests for Diagnosing Cushing's Syndrome

A doctor will begin by ordering initial screening tests and may order additional follow-up testing and imaging studies [29., 30., 32.].

Initial Screening Tests

  • 24-Hour Urinary Free Cortisol Test
    • This test measures cortisol levels in the urine over a 24-hour period to provide an integrated assessment of cortisol secretion uninfluenced by cortisol-binding globulin (CBG) levels. 
  • Elevated cortisol levels on this test may indicate excessive cortisol with high sensitivity, especially when at least two collections are made to confirm the results.
  • Late-Night Salivary Cortisol Test
    • This test measures cortisol levels in saliva late at night, typically between 11:00 PM and midnight, when cortisol levels are generally at their lowest.
  • It demonstrates the loss of the normal circadian rhythm of cortisol secretion, which is characteristic of Cushing's syndrome.
  • Dexamethasone Suppression Test: this test can be done overnight or for up to 48 hours to determine the body’s response to dexamethasone, which will slow cortisol production in healthy people.
  • Overnight Dexamethasone Suppression Test
    • Involves administering 1 mg of dexamethasone orally at night and measuring serum cortisol the next morning. Inadequate suppression of cortisol suggests Cushing's syndrome.
  • Cortisol levels less than 1.8 μg/dl are suppressed, indicating a normal response.
  • 48-Hour Low-Dose Dexamethasone Suppression Test (2 mg/day)
    • Administers 0.5 mg of dexamethasone every six hours for 48 hours, with serum cortisol measured six hours after the last dose.
  • This test is considered more specific in excluding pseudo-Cushing's syndrome (PCS) and helps confirm Cushing's syndrome.
  • Sensitivity is reported as 100%, and specificity as 88%.

Confirmatory Tests

  • Midnight Serum Cortisol Test (Sleeping and Awake)
    • Measures serum cortisol at midnight, either during sleep or while awake, to detect the absence of the normal midnight cortisol drop, a key sign of Cushing's syndrome.
  • Blood draw requires specific procedures depending on whether the patient is asleep or awake.
  • The loss of the normal cortisol drop at night may confirm Cushing's syndrome, especially in cases with mild or cyclical disease.
  • Plasma ACTH Levels
    • Plasma ACTH levels help differentiate between ACTH-dependent and ACTH-independent forms of Cushing's syndrome.
  • Elevated ACTH levels (>4.4 pmol/L) typically indicate an ACTH-dependent source such as Cushing's disease (CD) caused by a pituitary adenoma or ectopic ACTH production from non-pituitary tumors.
  • Suppressed ACTH levels (<2.2 pmol/L) suggest an ACTH-independent form of Cushing's syndrome, such as an adrenal adenoma or carcinoma, which autonomously produces cortisol and suppresses ACTH secretion.
  • Low-Dose Dexamethasone Suppression Test (LDDST) with CRH Stimulation
    • Combines dexamethasone suppression with CRH stimulation to assess cortisol and ACTH response.
  • This test helps differentiate between Cushing’s disease and other causes of Cushing's syndrome by assessing the response to CRH after dexamethasone suppression. It’s particularly useful in patients with equivocal results from other tests.
  • CRH is administered after completing a 48-hour dexamethasone suppression test, and cortisol and ACTH levels are measured 15 minutes later.
  • Desmopressin (dDAVP) Test
    • Involves administering desmopressin intravenously and measuring the subsequent rise in ACTH and cortisol levels to help differentiate between Cushing's disease (CD) and pseudo-Cushing's syndrome (PCS).

Imaging Studies to Identify the Source of Excess Cortisol

Guidelines for diagnosis of Cushing's syndrome emphasize that imaging, such as pituitary or adrenal imaging, is not recommended for initial testing to diagnose Cushing's syndrome. Instead, the diagnosis should start with biochemical tests to assess cortisol levels.

Imaging tests are typically reserved for later stages in the diagnostic process, specifically after biochemical confirmation of hypercortisolism.

The following imaging studies are used to identify the source of excess cortisol production: 

MRI (Magnetic Resonance Imaging)

Pituitary MRI is recommended for detecting microadenomas (often <10 mm) in suspected Cushing's disease (ACTH-dependent). MRI is highly sensitive to small tumors. Further tests may be needed to confirm the diagnosis if no tumor is found.

CT Scans (Computed Tomography)

Adrenal CT scans are suggested for ACTH-independent Cushing's to detect adrenal adenomas, carcinomas, or hyperplasia. CT can also help locate small ectopic ACTH-producing tumors in the chest, abdomen, or pelvis.

PET Scans (Positron Emission Tomography)

PET scans are used when ectopic ACTH production is suspected but not detected by CT or MRI. 

PET effectively identifies small neuroendocrine tumors with specific tracers, especially when biochemical tests indicate ectopic ACTH production, but conventional imaging (CT or MRI) fails to find a source.

Bilateral Inferior Petrosal Sinus Sampling (BIPSS)

BIPSS helps differentiate between pituitary and ectopic ACTH sources when imaging is inconclusive. 

It measures ACTH levels from the petrosal sinuses and peripheral blood, with a higher gradient indicating a pituitary source (Cushing's disease). This test is highly sensitive and specific, especially when MRI does not clearly show a tumor.

Differential Diagnosis: Ruling Out Other Conditions

Ruling out conditions with a similar symptom picture is important to arrive at the correct diagnosis.

Conditions with Similar Symptoms

Cushing’s Syndrome from Excessive Corticosteroid or Medication Use

Before running laboratory assessments, a thorough medication and health history assessment should be done to rule this out.

Pseudo-Cushing's Syndrome (PCS) and Subclinical Cushing's Syndrome (SCS)

Pseudo-Cushing’s Syndrome mimics Cushing’s Syndrome but is caused by chronic stress conditions like alcoholism or severe obesity.  Differentiating from true Cushing’s requires tests like the desmopressin test or midnight serum cortisol.

Subclinical Cushing’s Syndrome involves excess cortisol without obvious clinical signs. It is often associated with adrenal incidentalomas and is difficult to diagnose.

Cyclical Cushing's Syndrome

Characterized by fluctuating cortisol levels and intermittent symptoms, cyclical Cushing’s syndrome can be difficult to diagnose. Prolonged testing over a 28-day period or more is often necessary.

Cyclical Cushing's syndrome can be ACTH-dependent or independent, with varying symptom presentations depending on cycle duration and timing. Diagnosis requires at least three hypercortisolism episodes alternating with two normal cortisol periods.

Differentiating Between Cushing's Syndrome and Cushing's Disease

Cushing's syndrome is caused by prolonged high cortisol levels from either endogenous sources (like an adrenal tumor or ACTH-secreting pituitary adenoma) or exogenous sources (such as prolonged corticosteroid use).

Cushing's disease is a specific form of Cushing's syndrome caused by an ACTH-secreting pituitary adenoma. This pituitary adenoma is typically discovered on MRI.

Importance of Accurate Diagnosis

Correct identification of the cause of Cushing's syndrome is necessary because treatment varies based on the source of excess cortisol. 

  • If the syndrome is due to an ACTH-secreting pituitary adenoma (Cushing's disease), the primary treatment is usually surgical removal of the adenoma. For adrenal tumors, adrenalectomy is often required. 
  • If the cause is ectopic ACTH secretion from non-pituitary tumors, treatment focuses on locating and medically managing the tumor. 

Misidentification of the cause could lead to ineffective or harmful treatments, so accurate diagnosis is essential for effective management and improved patient outcomes.

Next Steps After Diagnosis

After diagnosis, treatment and monitoring come next:

Treatment Options

Treatment for endogenous Cushing's syndrome typically involves surgical removal of the cause: transsphenoidal adenomectomy for pituitary tumors, adrenalectomy for adrenal lesions, and tumor resection for ectopic ACTH-secretion. 

Bilateral adrenalectomy is reserved for severe cases or treatment failures. 

Radiation therapy is considered for patients unresponsive to surgery or with recurrent disease.

Medical options include steroidogenesis inhibitors (ketoconazole, metyrapone, mitotane) for those who can't undergo surgery or while awaiting radiation. Pituitary-directed drugs (cabergoline, pasireotide) and glucocorticoid antagonists (mifepristone) are alternatives for persistent disease. Combination therapy may be needed in severe cases.

For exogenous Cushing's syndrome, gradually reducing corticosteroids, especially after prolonged use. Alternate-day dosing and hydrocortisone replacement may also be considered.

Glucocorticoids should only be discontinued when the underlying disease is in long-term remission; otherwise, alternative treatments are necessary. 

Monitoring and Follow-Up

Even after hypercortisolism is controlled, ongoing monitoring is crucial for persistent issues like hypertension, diabetes, and cardiovascular problems. 

Long-term care and regular follow-ups are needed to ensure cortisol levels normalize and to manage Cushing-associated comorbidities, including cardiovascular problems, osteoporosis, and psychiatric symptoms. 

Lifelong monitoring for disease recurrence is recommended to ensure early detection and intervention.

Preparing for Treatment

Preparation and recovery from Cushing's treatment require careful planning and ongoing management. 

Unfortunately, patients can feel unprepared for the lengthy recovery, often citing inadequate information and support from healthcare providers. 

Effective recovery involves not only stopping cortisol replacement medication (CRM) when adrenal function normalizes but also managing persistent symptoms like pain, fatigue, and neuropsychiatric issues. 

Support systems, including family, friends, and support groups, are essential, and patients are encouraged to prioritize rest over physically demanding activities. 

Organizations like the Cushing’s Support and Research Foundation can aid your journey.

[signup]

Key Takeaways

  • Diagnosing Cushing's syndrome requires a thorough evaluation, including medical history, physical exams, specific biochemical tests, and imaging studies to identify the source of excess cortisol.
  • Early detection of Cushing's syndrome can be life-changing; if you notice symptoms like central weight gain, skin changes, or mood disturbances, consult your healthcare provider promptly, especially if you have a history of prolonged corticosteroid use. Timely intervention can help prevent complications and improve health outcomes.
  • Effective treatments for Cushing’s Syndrome, including surgery, medical therapy, and radiation, can lead to remission and significant improvement in quality of life; with proper care and support, many patients successfully recover and regain their health.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. Acree, R., Miller, C.M., Abel, B.S., Neary, N.M., Campbell, K.K., & Nieman, L.K. (2021). Patient and Provider Perspectives on Postsurgical Recovery of Cushing Syndrome. Journal of the Endocrine Society, 5 8, bvab109 .
  1. Adrenalectomy: When You Might Need Adrenal Gland Removal. (n.d.). Cleveland Clinic. https://my.clevelandclinic.org/health/procedures/adrenalectomy-adrenal-gland-removal 
  1. Albiger, N. M., Scaroni, C. M., & Mantero, F. (2007). Cyclic Cushing's syndrome: an overview. Arquivos brasileiros de endocrinologia e metabologia, 51(8), 1253–1260. https://doi.org/10.1590/s0004-27302007000800011
  1. Arroyo, R., Belmontes, P., Marlene, Mendoza, R., Gonzalez, B. E., Bonilla, N. C., Aran, & Santiago, G. G. (2023). Drug induced iatrogenic Cushing’s syndrome. International Journal of Research in Medical Sciences, 12(1), 303–308. https://doi.org/10.18203/2320-6012.ijrms20234026
  1. Barbot, M., Ceccato, F., & Scaroni, C. (2019). The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome. Frontiers in endocrinology, 10, 321. https://doi.org/10.3389/fendo.2019.00321
  1. Buliman, A., Tataranu, L. G., Paun, D. L., Mirica, A., & Dumitrache, C. (2016). Cushing's disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment. Journal of medicine and life, 9(1), 12–18.
  1. Castinetti, F., Morange, I., Conte-Devolx, B., & Brue, T. (2012). Cushing’s disease. Orphanet Journal of Rare Diseases, 7(1), 41. https://doi.org/10.1186/1750-1172-7-41
  1. Chaudhry HS, Singh G. Cushing Syndrome. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470218/
  1. Chen, Y., Li, Y., Chen, X., & Sun, Q. (2013). Neuropsychiatric disorders and cognitive dysfunction in patients with Cushing’s disease. Chinese Medical Journal, 126(16), 3156–3160. https://doi.org/10.3760/cma.j.issn.0366-6999.20130944
  1. Cizza, G., & Chrousos, G. P. (1997). Adrenocorticotrophic hormone-dependent Cushing's syndrome. Cancer treatment and research, 89, 25–40. https://doi.org/10.1007/978-1-4615-6355-6_2
  1. Cloyd, J. A Root Cause Medicine Protocol For Patients With Osteoporosis: Testing, Therapeutic Diet, and Supportive Supplements. (2023, September 6). Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-protocol-for-patients-with-osteoporosis-testing-therapeutic-diet-and-supportive-supplements
  1. Cloyd, J. Cortisol and Anxiety: Understanding the Connection. (2024, June 7). Rupa Health. https://www.rupahealth.com/post/cortisol-and-anxiety
  1. Cloyd, J. Cortisol and Weight Gain: Understanding the Connection. (2024, April 15). Rupa Health. https://www.rupahealth.com/post/cortisol-and-weight-gain-understanding-the-connection 
  1. Cloyd, J. How To Interpret Your Cortisol Urine Test Results. (2023, October 30). Rupa Health. https://www.rupahealth.com/post/how-to-interpret-your-cortisol-urine-test-results 
  1. Cloyd, J. Saliva Testing: Cortisol and Hormone Test Result Interpretation Guide. (2024, January 3). Rupa Health. https://www.rupahealth.com/post/saliva-testing-cortisol-and-hormone-test-result-interpretation-guide
  1. Cloyd, J. (2023, May 17). The Role Of Nutrition And Dietary Supplements In Preventing And Managing Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/the-role-of-nutrition-and-dietary-supplements-in-preventing-and-managing-cardiovascular-disease
  1. Cloyd, J. Utilizing Functional Medicine Labs In Practice To Help Individualize Nutrition Options for Type 2 Diabetics. (2023, June 27). Rupa Health. https://www.rupahealth.com/post/3-functional-medicine-labs-that-can-help-individualize-nutrition-options-for-type-2-diabetics 
  1. Cloyd, J. (2024, March 1). What is Hyperlipidemia? Symptoms, Testing, and Treatments. Rupa Health. https://www.rupahealth.com/post/what-is-hyperlipidemia-symptoms-testing-and-treatments 
  1. Cortisol, Free, 24 Hour, Urine - Mayo Clinic Laboratories | Endocrinology Catalog. (2018). Testcatalog.org. https://endocrinology.testcatalog.org/show/CORTU#:~:text=Most%20patients%20with%20Cushing%20syndrome 
  1. Cortisone Shots: How They Work and Side Effects. (2024). Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/cortisone-shots-steroid-injections
  1. Diorio, B. (2023, January 27). Functional medicine labs that are important for longevity and cognition. Rupa Health. https://www.rupahealth.com/post/functional-medicine-labs-that-are-important-to-longevity-and-cognition 
  1. DynaMedex. (2024). Dynamedex.com. https://www.dynamedex.com/evaluation/cushing-syndrome-diagnostic-approach
  1. Ferraù, F., & Korbonits, M. (2015). Metabolic comorbidities in Cushing’s syndrome. European Journal of Endocrinology, 173(4), M133–M157. https://doi.org/10.1530/eje-15-0354
  1. Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., Casanueva, F. F., Castinetti, F., Chanson, P., Findling, J., Gadelha, M., Geer, E. B., Giustina, A., Grossman, A., Gurnell, M., Ho, K., … Biller, B. M. K. (2021). Consensus on diagnosis and management of Cushing's disease: a guideline update. The lancet. Diabetes & endocrinology, 9(12), 847–875. https://doi.org/10.1016/S2213-8587(21)00235-7
  1. Halimova, Z., & Irgasheva, O. B. (2021). Turakulov Republican Specialized Scientific and Practical Medical Center of Endocrinology of the Ministry of Health of the Republic of Uzbekistan, Tashkent, Republic of Uzbekistan. INTERNATIONAL JOURNAL of ENDOCRINOLOGY (Ukraine), 16(4), 310–315. https://doi.org/10.22141/2224-0721.16.4.2020.208483
  1. John Hopkins Medicine. (2024). Adrenal Glands. Johns Hopkins Medicine Health Library. https://www.hopkinsmedicine.org/health/conditions-and-diseases/adrenal-glands 
  1. Kairys N, Anastasopoulou C, Schwell A. Cushing Disease. [Updated 2023 Feb 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448184/
  1. Khakham, C. Top Labs To Run Bi-Annually On Your Depression Patients. (2023, July 28). Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-depression-patients
  1. Khakham, C. (2023, August 25). Top Labs To Run Bi-Annually On Your High Blood Pressure Patients. Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-high-blood-pressure-patients
  1. Khakham, C. Top Labs To Run Bi-Annually On Your Male Low Libido Patients. (2023, August 4). Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-male-low-libido-patients
  1. Kiałka, M., Doroszewska, K., Mrozińska, S., Milewicz, T., & Stochmal, E. (2015). Cykliczny zespół Cushinga - rzadki czy rzadko rozpoznawany? [Cyclic Cushing's Syndrome - rare or rarely recognized]. Przeglad lekarski, 72(2), 74–77.
  1. Kreitschmann-Andermahr, I., Psaras, T., Tsiogka, M., Starz, D., Kleist, B., Siegel, S., Milian, M., Kohlmann, J., Menzel, C., Führer-Sakel, D., Honegger, J., Sure, U., Müller, O., & Buchfelder, M. (2015). From first symptoms to final diagnosis of Cushing's disease: experiences of 176 patients. European journal of endocrinology, 172(3), 285–289. https://doi.org/10.1530/EJE-14-0766
  1. Mann, M., Koller, E., Murgo, A., Malozowski, S., Bacsanyi, J., & Leinung, M. (1997). Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Archives of internal medicine, 157(15), 1651–1656. https://doi.org/10.1001/archinte.157.15.1651
  1. Menconi, M., Fareed, M., O'Neal, P., Poylin, V., Wei, W., & Hasselgren, P. O. (2007). Role of glucocorticoids in the molecular regulation of muscle wasting. Critical care medicine, 35(9 Suppl), S602–S608. https://doi.org/10.1097/01.CCM.0000279194.11328.77
  1. Nath, A., Murthy, G.V.S., Babu, G.R. et al. Effect of prenatal exposure to maternal cortisol and psychological distress on infant development in Bengaluru, southern India: a prospective cohort study. BMC Psychiatry 17, 255 (2017). https://doi.org/10.1186/s12888-017-1424-x
  1. Neibling, K. (2023, April 26). Complementary and Integrative Medicine Treatments for Hypertension and Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-treatments-for-hypertension-and-cardiovascular-disease 
  1. Nieman L. K. (2018). Recent Updates on the Diagnosis and Management of Cushing's Syndrome. Endocrinology and metabolism (Seoul, Korea), 33(2), 139–146. https://doi.org/10.3803/EnM.2018.33.2.139
  1. Nieman, L. K., Biller, B. M., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008). The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism, 93(5), 1526–1540. https://doi.org/10.1210/jc.2008-0125
  1. Nieman, L. K., Biller, B. M., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., Tabarin, A., & Endocrine Society (2015). Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism, 100(8), 2807–2831. https://doi.org/10.1210/jc.2015-1818
  1. Pappachan, J. M., Hariman, C., Edavalath, M., Waldron, J., & Hanna, F. W. (2017). Cushing’s syndrome: a practical approach to diagnosis and differential diagnoses. Journal of Clinical Pathology, 70(4), 350–359. https://doi.org/10.1136/jclinpath-2016-203933
  1. Ramírez-Villaescusa, J., Ruiz-Picazo, D., Oliveira, C. L., & Morillas-Ariño, C. (2020). Secondary thoracolumbar deformity and sagittal imbalance due to osteoporosis in a young man with Cushing's disease: A case report. International journal of surgery case reports, 76, 134–138. https://doi.org/10.1016/j.ijscr.2020.09.182
  1. Salvio, G., Martino, M., Giancola, G., Arnaldi, G., & Balercia, G. (2021). Hypothalamic–Pituitary Diseases and Erectile Dysfunction. Journal of Clinical Medicine, 10(12), 2551. https://doi.org/10.3390/jcm10122551
  1. Steffensen, C., Bak, A. M., Rubeck, K. Z., & Jørgensen, J. O. (2010). Epidemiology of Cushing's syndrome. Neuroendocrinology, 92 Suppl 1, 1–5. https://doi.org/10.1159/000314297
  1. Stratakis C. A. (2016). Skin manifestations of Cushing's syndrome. Reviews in endocrine & metabolic disorders, 17(3), 283–286. https://doi.org/10.1007/s11154-016-9399-3
  1. Tomita A. (1998). Nihon rinsho. Japanese journal of clinical medicine, 56(6), 1574–1578.
  1. Weinberg, J. 34 Million Americans Have This Symptomless Bone Condition - Here’s How You Can Prevent It. (2022, August 16). Rupa Health. https://www.rupahealth.com/post/osteopenia-prevention 
  1. Weinberg, J. ACTH Hormone: Roles, Regulation, and Health Implications. (2024, April 5). Rupa Health. https://www.rupahealth.com/post/acth-hormone-roles-regulation-and-health-implications
  1. Weinberg, J. (2024, March 6). What is Cushing’s Syndrome?: Testing and Treatments. Rupa Health. https://www.rupahealth.com/post/what-is-cushings-syndrome-testing-and-treatments
  1. Zubair, A., & M Das, J. (2020). Transsphenoidal Hypophysectomy. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK556142/
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Adrenal
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a Free Live Class that dives into how popular diets impact the gut microbiome, the clinical dietary needs of your gut, biomarkers to test to analyze gut health, and gain a clear understanding of the Doctor’s Data GI360™ profile. Register here.